{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:12:07Z","timestamp":1790727127287,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:00:00Z","timestamp":1529452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:00:00Z","timestamp":1529452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K08586"],"award-info":[{"award-number":["17K08586"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K11047"],"award-info":[{"award-number":["17K11047"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K15661"],"award-info":[{"award-number":["15K15661"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00210-018-1527-z","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T01:58:59Z","timestamp":1529459939000},"page":"1021-1032","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Cardioprotective and functional effects of levosimendan and milrinone in mice with cecal ligation and puncture-induced sepsis"],"prefix":"10.1007","volume":"391","author":[{"given":"Shigeyuki","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yokoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohshi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshi","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,20]]},"reference":[{"key":"1527_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0014-2999(01)01569-2","volume":"435","author":"Y Ajiro","year":"2002","unstructured":"Ajiro Y, Hagiwara N, Katsube Y, Sperelaxis N, Kasanuki H (2002) Levosimendan increases L-type Ca2+ current via phosphodiesterase-3 inhibition in human cardiac myocytes. Eur J Pharmacol 435:27\u201333","journal-title":"Eur J Pharmacol"},{"key":"1527_CR2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1365-2125.2003.02043.x","volume":"57","author":"S Antila","year":"2004","unstructured":"Antila S, Kivikko M, Lehtonen L, Eha J, Heikkil\u00e4 A, Pohjanjousi P, Pentik\u00e4inen PJ (2004) Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan. Br J Clin Pharmacol 57:412\u2013415","journal-title":"Br J Clin Pharmacol"},{"key":"1527_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1001\/jama.1994.03510270072043","volume":"271","author":"AL Beal","year":"1994","unstructured":"Beal AL, Cerra FB (1994) Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 271:226\u2013233","journal-title":"JAMA"},{"key":"1527_CR4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/0002-9149(85)91036-7","volume":"56","author":"JR Benotti","year":"1985","unstructured":"Benotti JR, Lesko LJ, McCue JE, Alpert JS (1985) Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure. Am J Cardiol 56:685\u2013689","journal-title":"Am J Cardiol"},{"key":"1527_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1186\/cc1822","volume":"6","author":"O Court","year":"2002","unstructured":"Court O, Kumar A, Parrillo JE, Kumar A (2002) Clinical review: myocardial depression in sepsis and septic shock. Crit Care 6:500\u2013508","journal-title":"Crit Care"},{"key":"1527_CR6","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1253\/circj.CJ-08-0838","volume":"72","author":"M Endoh","year":"2008","unstructured":"Endoh M (2008) Cardiac Ca2+ signaling and Ca2+ sensitizers. Circ J 72:1915\u20131925","journal-title":"Circ J"},{"key":"1527_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.acthis.2008.09.010","volume":"111","author":"K Erb\u00fcy\u00fcn","year":"2009","unstructured":"Erb\u00fcy\u00fcn K, Vatansever S, Tok D, Ok G, T\u00fcrk\u00f6z E, Aydede H, Erhan Y, Tekin \u0130 (2009) Effects of levosimendan and dobutamine on experimental acute lung injury in rats. Acta Histochem 111:404\u2013414","journal-title":"Acta Histochem"},{"key":"1527_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ccm.2016.01.008","volume":"37","author":"JP Gelinas","year":"2016","unstructured":"Gelinas JP, Russell JA (2016) Vasopressors during sepsis: selection and targets. Clin Chest Med 37:251\u2013262","journal-title":"Clin Chest Med"},{"key":"1527_CR9","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","volume":"375","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RML, Santhakumaran S, Mason AJ, Cross M, Al-Beidh F, Best-Lane J, Brealey D, Nutt CL, McNamee JJ, Reschreiter H, Breen A, Liu KD, Ashby D (2016) Levosimendan for prevention of acute organ dysfunction in sepsis. N Engl J Med 375:1638\u20131648","journal-title":"N Engl J Med"},{"key":"1527_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/FJC.0000000000000551","volume":"71","author":"F Guarracino","year":"2018","unstructured":"Guarracino F, Heringlake M, Cholley B, Bettex D, Bouchez S, Lomivorotov VV, Rajek A, Kivikko M, Pollesello P (2018) Use of levosimendan in cardiac surgery: an update after the LEVO-CTS, CHEETAH, and LICORN Trials in the light of clinical practice. J Cardiovasc Pharmacol 71:1\u20139","journal-title":"J Cardiovasc Pharmacol"},{"key":"1527_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/SHK.0000000000000851","volume":"48","author":"Z Hajjej","year":"2017","unstructured":"Hajjej Z, Meddeb B, Sellami W, Labbene I, Morelli A, Ferjani M (2017) Effects of levosimendan on cellular metabolic alterations in patients with septic shock: a randomized controlled pilot study. Shock 48:307\u2013312","journal-title":"Shock"},{"key":"1527_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40635-016-0109-y","volume":"4","author":"M Hattori","year":"2016","unstructured":"Hattori M, Yamazaki M, Ohashi W, Tanaka S, Hattori K, Todoroki K, Fujimori T, Ohtsu H, Matsuda N, Hattori Y (2016) Critical role of endogenous histamine in promoting end-organ tissue injury in sepsis. Intensive Care Med Exp 4:36","journal-title":"Intensive Care Med Exp"},{"key":"1527_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1161\/CIRCULATIONAHA.105.542407","volume":"113","author":"DA Kass","year":"2006","unstructured":"Kass DA, Solaro RJ (2006) Mechanisms and use of calcium-sensitizing agents in the failing heart. Circulation 113:305\u2013315","journal-title":"Circulation"},{"issue":"Suppl 1","key":"1527_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.shk.0000191383.34066.4b","volume":"24","author":"JC Marshall","year":"2005","unstructured":"Marshall JC, Deitch E, Moldawer LL, Opal S, Redl H, van der Poll T (2005) Preclinical models of shock and sepsis: what can they tell us? Shock 24(Suppl 1):1\u20136","journal-title":"Shock"},{"key":"1527_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1399-6576.2005.00541.x","volume":"49","author":"M Matejovic","year":"2005","unstructured":"Matejovic M, Krouzecky A, Radej J, Novak I (2005) Successful reversal of resistent hypodynamic septic shock with levosimendan. Acta Anaesthesiol Scand 49:127\u2013128","journal-title":"Acta Anaesthesiol Scand"},{"key":"1527_CR16","doi-asserted-by":"publisher","first-page":"H92","DOI":"10.1152\/ajpheart.00069.2009","volume":"298","author":"N Matsuda","year":"2010","unstructured":"Matsuda N, Teramae H, Yamamoto S, Takano K, Takano Y, Hattori Y (2010) Increased death receptor pathway of apoptotic signaling in septic mouse aorta: effect of systemic delivery of FADD siRNA. Am J Physiol Heart Circ Physiol 298:H92\u2013H101","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1527_CR17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/00024382-200014060-00014","volume":"14","author":"MJ Ming","year":"2000","unstructured":"Ming MJ, Hu DY, Chen HS, Liu LM, Nan X, Hua CH, Lu RQ (2000) Effect of MCI-154, a calcium sensitizer, on calcium sensitivity of myocardial fibers in endotoxic shock rats. Shock 14:652\u2013656","journal-title":"Shock"},{"key":"1527_CR18","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00134-005-2619-z","volume":"31","author":"A Morelli","year":"2005","unstructured":"Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, De Luca L, Di Angelantonio E, Orecchioni A, Pandian NG, Pietropaoli P (2005) Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 31:638\u2013644","journal-title":"Intensive Care Med"},{"key":"1527_CR19","first-page":"L130","volume":"303","author":"H Oishi","year":"2012","unstructured":"Oishi H, Takano K, Tomita K, Takebe M, Yokoo H, Yamazaki M, Hattori Y (2012) Olprinone and colforsin daropate alleviate septic lung inflammation and apoptosis through CREB-independent activation of the Akt pathway. Am J Phys Lung Cell Mol Phys 303:L130\u2013L140","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"1527_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1527-3466.2005.tb00158.x","volume":"23","author":"Z Papp","year":"2005","unstructured":"Papp Z, Csap\u00f3 K, Pollesello P, Haikala H, Edes I (2005) Pharmacological mechanisms contributing to the clinical efficacy of levosimendan. Cardiovasc Drug Rev 23:71\u201398","journal-title":"Cardiovasc Drug Rev"},{"key":"1527_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1568016054368232","volume":"3","author":"IA Paraskevaidis","year":"2005","unstructured":"Paraskevaidis IA, Parissis JT, Th Kremastinos D (2005) Anti-inflammatory and anti-apoptotic effects of levosimendan in decompensated heart failure: a novel mechanism of drug-induced improvement in contractile performance of the failing heart. Curr Med Chem Cardiovasc Hematol Agents 3:243\u2013247","journal-title":"Curr Med Chem Cardiovasc Hematol Agents"},{"key":"1527_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.7326\/0003-4819-113-3-227","volume":"113","author":"JE Parrillo","year":"1990","unstructured":"Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP (1990) Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113:227\u2013242","journal-title":"Ann Intern Med"},{"key":"1527_CR23","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.amjcard.2004.11.018","volume":"95","author":"JT Parrisis","year":"2005","unstructured":"Parrisis JT, Farmakis D, Th Kremastinos D (2005) Anti-inflammatory effects of levosimendan in decompensated heart failure: impact on weight loss and anemia. Am J Cardiol 95:923\u2013924","journal-title":"Am J Cardiol"},{"key":"1527_CR24","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43:304\u2013377","journal-title":"Intensive Care Med"},{"key":"1527_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2165\/00003088-198713020-00002","volume":"13","author":"ML Rocci Jr","year":"1987","unstructured":"Rocci ML Jr, Wilson H (1987) The pharmacokinetics and pharmacodynamics of newer inotropic agents. Clin Pharmacokinet 13:91\u2013109","journal-title":"Clin Pharmacokinet"},{"key":"1527_CR26","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1097\/01.CCM.0000266683.64081.02","volume":"35","author":"A Rudiger","year":"2007","unstructured":"Rudiger A, Singer M (2007) Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35:1599\u20131608","journal-title":"Crit Care Med"},{"key":"1527_CR27","doi-asserted-by":"publisher","first-page":"H1224","DOI":"10.1152\/ajpheart.00828.2016","volume":"312","author":"M Sakai","year":"2017","unstructured":"Sakai M, Suzuki T, Tomita K, Yamashita S, Palikhe S, Hattori K, Yoshimura N, Matsuda N, Hattori Y (2017) Diminished responsiveness to dobutamine as an inotrope in mice with cecal ligation and puncture-induced sepsis: attribution to phosphodiesterase 4 upregulation. Am J Physiol Heart Circ Physiol 312:H1224\u2013H1237","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1527_CR28","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/bjp.2008.328","volume":"155","author":"O Sareila","year":"2008","unstructured":"Sareila O, Korhonen R, Auvinen H, H\u00e4m\u00e4l\u00e4inen M, Kankaanranta H, Nissinen E, Moilanen E (2008) Effects of levo- and dextrosimendan on NF-\u03baB-mediated transcription, iNOS expression and NO production in response to inflammatory stimuli. Br J Pharmacol 155:884\u2013895","journal-title":"Br J Pharmacol"},{"key":"1527_CR29","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s00134-009-1481-9","volume":"35","author":"P Scheiermann","year":"2009","unstructured":"Scheiermann P, Ahluwalia D, Hoegl S, Dolfen A, Revermann M, Zwissler B, Muhl H, Boost KA, Hofstetter C (2009) Effects of intravenous and inhaled levosimendan in severe rodent sepsis. Intensive Care Med 35:1412\u20131419","journal-title":"Intensive Care Med"},{"key":"1527_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801\u2013810","journal-title":"JAMA"},{"key":"1527_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","volume":"9","author":"G Song","year":"2005","unstructured":"Song G, Ouyang G, Bao S (2005) The activation of Akt\/PKB signaling pathway and cell survival. J Cell Mol Med 9:59\u201371","journal-title":"J Cell Mol Med"},{"key":"1527_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/SHK.0000000000000138","volume":"41","author":"R Thangamalai","year":"2014","unstructured":"Thangamalai R, Kandasamy K, Sukumarin SV, Reddy N, Singh V, Choudhury S, Parida S, Singh TU, Boobalan R, Mishra SK (2014) Atorvastatin prevents sepsis-induced downregulation of myocardial \u03b21-adrenoceptors and decreased cAMP response in mice. Shock 41:406\u2013412","journal-title":"Shock"},{"key":"1527_CR33","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jss.2014.09.012","volume":"193","author":"K Tomita","year":"2015","unstructured":"Tomita K, Takashina M, Mizuno N, Sakata K, Hattori K, Imura J, Ohashi W, Hattori Y (2015) Cardiac fibroblasts: contributory role in septic cardiac dysfunction. J Surg Res 193:874\u2013887","journal-title":"J Surg Res"},{"key":"1527_CR34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1186\/s13054-014-0652-4","volume":"18","author":"CM Tsao","year":"2014","unstructured":"Tsao CM, Li KY, Chen SJ, Ka SM, Liaw WJ, Huang HC, Wu CC (2014) Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model. Crit Care 18:652","journal-title":"Crit Care"},{"key":"1527_CR35","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1097\/CCM.0b013e318174db05","volume":"36","author":"A Vieillard-Baron","year":"2008","unstructured":"Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F (2008) Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 36:1701\u20131706","journal-title":"Crit Care Med"},{"key":"1527_CR36","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1097\/CCM.0000000000001269","volume":"43","author":"Q Wang","year":"2015","unstructured":"Wang Q, Yokoo H, Takashina M, Sakata K, Ohashi W, Abedelzaher LA, Imaizumi T, Sakamoto T, Hattori K, Matsuda N, Hattori Y (2015) Anti-inflammatory profile of levosimendan in cecal ligation-induced septic mice and in lipopolysaccharide-stimulated macrophages. Crit Care Med 43:e508\u2013e520","journal-title":"Crit Care Med"},{"key":"1527_CR37","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00210-008-0270-2","volume":"377","author":"Y Watanabe","year":"2008","unstructured":"Watanabe Y, Kimura J (2008) Acute inhibitory effect of dronedarone, a noniodinated benzofuran analogue of amiodarone, on Na+\/Ca2+ exchange current in guinea pig ventricular myocytes. Naunyn Schmiedeberg\u2019s Arch Pharmacol 377:371\u2013376","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"1527_CR38","first-page":"R408","volume":"281","author":"LL Wu","year":"2001","unstructured":"Wu LL, Tang C, Liu MS (2001) Altered phosphorylation and calcium sensitivity of cardiac myofibrillar proteins during sepsis. Am J Phys Regul Integr Comp Phys 281:R408\u2013R416","journal-title":"Am J Phys Regul Integr Comp Phys"},{"key":"1527_CR39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/MCC.0b013e3283307a4e","volume":"15","author":"SL Zanotti-Cavazzoni","year":"2009","unstructured":"Zanotti-Cavazzoni SL, Hollenberg SM (2009) Cardiac dysfunction in severe sepsis and septic shock. Curr Opin Crit Care 15:392\u2013397","journal-title":"Curr Opin Crit Care"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-018-1527-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-018-1527-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-018-1527-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:57:30Z","timestamp":1589619450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-018-1527-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,20]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["1527"],"URL":"https:\/\/doi.org\/10.1007\/s00210-018-1527-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,20]]},"assertion":[{"value":"5 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethical standards"}},{"value":"The authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal studies were approved by the Animal Care and Use Committee of the University of Toyama and the Animal Research Committee of Hamamatsu University School of Medicine, which are based on the National Institute of Health Guide for the Care and Use of Laboratory Animals and the ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}